Literature DB >> 34070278

Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer.

Melania Costantini1,2, Rino Aldo Montella1, Maria Paola Fadda1, Giorgia Garganese3,4, Alba Di Leone5, Alejandro Martin Sanchez5, Gianluca Franceschini5,6, Pierluigi Maria Rinaldi1,2.   

Abstract

Axillary lymph node metastases of occult breast cancer (CUPAx) is an unusual condition that represents both a diagnostic and therapeutic challenge. The first steps in the diagnostic work-up of patients with CUPAx are the histological analysis of the lymph node metastasis and the execution of basic breast diagnostic imaging (mammography and ultrasound). In the case of occult breast cancer, breast Magnetic Resonance (MR) must be performed. Breast MR identifies a suspicious lesion in many patients and second-look ultrasound detects a corresponding ultrasound alteration in about half of cases, allowing the performance of a US-guided biopsy. In the case of an MR-only lesion, MR-guided biopsy is mandatory. We present a case of CUPAx in which contrast-enhanced spectral mammography (CESM) is used to help the detection of occult breast cancer and to guide stereotactic vacuum breast biopsy (VABB). CESM is a new breast imaging technique that is proving to have good performance in breast cancer detection and that is showing potential in the identification of occult breast cancer in a CUPAx setting. The use of an innovative and personalized breast imaging approach in breast cancer patients improves diagnostic possibilities and promises to become the focus in decision strategies.

Entities:  

Keywords:  CUP syndrome; axillary lymph node metastases; breast imaging; contrast-enhanced spectral mammography; occult breast cancer

Year:  2021        PMID: 34070278     DOI: 10.3390/jpm11060465

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  32 in total

Review 1.  Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management.

Authors:  F Anthony Greco
Journal:  Curr Treat Options Oncol       Date:  2013-12

Review 2.  Magnetic resonance imaging: the evolution of breast imaging.

Authors:  Sylvia H Heywang-Köbrunner; Astrid Hacker; Stefan Sedlacek
Journal:  Breast       Date:  2013-08       Impact factor: 4.380

3.  Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).

Authors:  Damian P McCartan; Emily C Zabor; Monica Morrow; Kimberly J Van Zee; Mahmoud B El-Tamer
Journal:  Ann Surg Oncol       Date:  2017-07-12       Impact factor: 5.344

4.  Axillary lymph node metastases from unknown primary: A French multicentre study.

Authors:  Lobna Ouldamer; Marie Cayrol; Mathilde Vital; Claire Fièvre; Marion Druelles; Flavie Arbion; Gilles Body; Jean Lévêque; Xavier Fritel
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-02-23       Impact factor: 2.435

5.  Clinical experience with axillary presentation breast cancer.

Authors:  Viviana Galimberti; Gulliermo Bassani; Simonetta Monti; Serife Simsek; Gaetano Villa; Giuseppe Renne; Alberto Luini
Journal:  Breast Cancer Res Treat       Date:  2004-11       Impact factor: 4.872

6.  Carcinoma of Unknown Primary - an Orphan Disease?

Authors:  Alwin Krämer; Gerdt Hübner; Andreas Schneeweiss; Gunnar Folprecht; Kai Neben
Journal:  Breast Care (Basel)       Date:  2008-06-19       Impact factor: 2.860

Review 7.  Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence.

Authors:  George Pentheroudakis; George Lazaridis; Nicholas Pavlidis
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

8.  Update on the surgical management of breast cancer.

Authors:  Gianluca Franceschini; Alejandro Martin Sanchez; Alba Di Leone; Stefano Magno; Francesca Moschella; Cristina Accetta; Maria Natale; Danilo Di Giorgio; Assunta Scaldaferri; Sabatino D'Archi; Lorenzo Scardina; Riccardo Masetti
Journal:  Ann Ital Chir       Date:  2015 Mar-Apr       Impact factor: 0.766

Review 9.  Contrast-enhanced mammography: past, present, and future.

Authors:  Julie Sogani; Victoria L Mango; Delia Keating; Janice S Sung; Maxine S Jochelson
Journal:  Clin Imaging       Date:  2020-09-19       Impact factor: 1.605

10.  Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.

Authors:  Dong Xing; Yongbin Lv; Bolin Sun; Haizhu Xie; Jianjun Dong; Cuijuan Hao; Qianqian Chen; Xiaoxiao Chi
Journal:  J Comput Assist Tomogr       Date:  2019 Mar/Apr       Impact factor: 1.826

View more
  2 in total

1.  Contrast-Enhanced Spectral Mammography-Based Prediction of Non-Sentinel Lymph Node Metastasis and Axillary Tumor Burden in Patients With Breast Cancer.

Authors:  Xiaoqian Wu; Yu Guo; Yu Sa; Yipeng Song; Xinghua Li; Yongbin Lv; Dong Xing; Yan Sun; Yizi Cong; Hui Yu; Wei Jiang
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

2.  Personalized Approaches for the Prevention and Treatment of Breast Cancer.

Authors:  Hermann Nabi
Journal:  J Pers Med       Date:  2022-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.